Gabexin Mesilate in acute pancreatitis has what effect on mortality?

Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

Gabexin Mesilate in acute pancreatitis has what effect on mortality?

Gabexate mesilate was studied in acute pancreatitis because it acts as a serine protease inhibitor, aiming to slow pancreatic autodigestion and the inflammatory cascade. Despite this rationale, rigorous randomized trials and meta-analyses consistently show no reduction in mortality with gabexate compared with standard care. While other outcomes may vary, death rates do not improve, so the effect on mortality is effectively no effect.

Gabexate mesilate was studied in acute pancreatitis because it acts as a serine protease inhibitor, aiming to slow pancreatic autodigestion and the inflammatory cascade. Despite this rationale, rigorous randomized trials and meta-analyses consistently show no reduction in mortality with gabexate compared with standard care. While other outcomes may vary, death rates do not improve, so the effect on mortality is effectively no effect.

More practice questions